France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection – Labiotech.eu (blog)
Labiotech.eu (blog) |
France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection
Labiotech.eu (blog) French biotech TxCell is finalizing the preparations to take its first cell therapy to clinical trials. The treatment, called HLA-A2 CAR-Treg, is intended for the prevention of chronic rejection after organ transplantation. Out of the €5M needed to … Government funds TxCell's CAR-Treg therapy |
